Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2025-12-25 @ 4:18 AM
NCT ID:
NCT00722020
Eligibility Criteria:
Inclusion Criteria:
* Any pediatric patient between the ages of 18 months and 18 years admitted to Winthrop University Hospital's pediatric floor or intensive care unit with a diagnosis of asthma or reactive airway disease
Exclusion Criteria:
* Patients with chronic, comorbid respiratory conditions (e.g., cerebral palsy, cystic fibrosis)
* Those who regularly use HFCWO
* Any patient exhibiting an absolute contraindication to HFCWO therapy
* Absolute contraindications to using HFCWO include head and neck injury prior to stabilization, and active hemorrhage with hemodynamic instability
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Months
Maximum Age:
18 Years
Study:
NCT00722020
Study Brief:
Protocol Section:
NCT00722020